BridgeMD
New treatment option for Substance Use Disorders
Official title Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
ClinicalTrials.gov ID: NCT04939012
What this study is testing
- What it's testing
- This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Prenatal Cohort:
- Be greater than or equal to 18 years of age.
- Be pregnant with an EGA of 22 to 37 weeks at enrollment.
- Plan to deliver at research site.
- Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their...
You likely can't join if
- Have had a fetal or neonatal death with their current pregnancy.
- Be currently in jail or prison as required by court of law. Persons on probation or in residential facilities do not need to be excluded.
- Have any other condition (social or medical) which, in the opinion of the Investigator, would make study participation unsafe, make study...
- PPC ONLY: Documented tubal ligation or hysterectomy procedures at time of delivery hospitalization
See the full eligibility criteria
- Prenatal Cohort:
- Be greater than or equal to 18 years of age.
- Be pregnant with an EGA of 22 to 37 weeks at enrollment.
- Plan to deliver at research site.
- Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record. Postpartum Cohort:
- Be greater than or equal to 18 years of age.
- Be 0-9 days postpartum at enrollment.
- Have delivered at research site.
- Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.
- Have had a fetal or neonatal death with their current pregnancy.
- Be currently in jail or prison as required by court of law. Persons on probation or in residential facilities do not need to be excluded.
- Have any other condition (social or medical) which, in the opinion of the Investigator, would make study participation unsafe, make study participation difficult, and/or complicate data interpretation.
- PPC ONLY: Documented tubal ligation or hysterectomy procedures at time of delivery hospitalization
The study team makes the final eligibility decision.
Where it's taking place
- Pittsburgh, Pennsylvania, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.